Verapamil Hydrochloride Extended-Release Tablets — Class II drug recall D-0536-2023
Terminated recall by Amerisource Health Services LLC, reported 2023-04-26, distributed nationwide. Failed Dissolution Specifications: Out of specification dissolution results above specified values.
| Recall number | D-0536-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Amerisource Health Services LLC, Columbus, OH, United States |
| Recall initiated | 2023-03-16 |
| Classified | 2023-04-14 |
| Reported by FDA | 2023-04-26 |
| Terminated | 2024-05-12 |
| Distributed | Nationwide (US) |
| Quantity | 695 cartons |
| Reason classes | specification failure |
| NDC | 60687-0504-01, 60687-0504-11 |
| Lot numbers | 1008622, 1010026 |
| Expiration dates | 2024-02-29 |
Product
Verapamil Hydrochloride Extended-Release Tablets, USP, 180 mg, 100 Tablets (10 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-504-01; NDC Unit Dose: 60687-504-11, barcode (01) 003 60687 504 11 7.
Reason for recall
Failed Dissolution Specifications: Out of specification dissolution results above specified values.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0536-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.